$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

$cloq Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224011921 Filed on March 29, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$15.00K	$15.99K
YoY Change		461.8%	498.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$12.07K	$98.64K	$342.4K
YoY Change	152.34%	-85.33%	1280.91%
% of Gross Profit
Research & Development		$11.04K	$11.04K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$162.0K	$110.7K	$383.2K
YoY Change	73.34%	-83.85%	-44.05%
Operating Profit	-$162.0K		-$367.3K
YoY Change	73.34%		-46.18%
Interest Expense	-$55.97K	-$278.0K	-$659.3K
YoY Change	-53.46%	233.23%	690.41%
% of Operating Profit
Other Income/Expense, Net	-$55.97K		-$659.3K
YoY Change	-53.46%		122.2%
Pretax Income	-$218.0K	-$373.6K	-$1.027M
YoY Change	1.99%	-61.84%	4.85%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$218.0K	-$373.6K	-$1.027M
YoY Change	1.99%	-61.84%	4.85%
Net Earnings / Revenue		-2490.6%	-6419.82%
Basic Earnings Per Share	$0.00		$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	124.9M shares	121.6M shares
Diluted Shares Outstanding	125.5M shares		121.0M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$141.5K	$307.2K	$307.2K
YoY Change	505.78%	7447.17%	7447.17%
Cash & Equivalents	$141.5K	$307.2K
Short-Term Investments
Other Short-Term Assets	$56.23K	$44.56K	$44.56K
YoY Change	-29.18%	-17.19%	-17.19%
Inventory
Prepaid Expenses
Receivables		$10.00K	$10.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$197.7K	$361.7K	$361.7K
YoY Change	92.44%	525.0%	524.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.305M	$1.097M
YoY Change	121.25%	287.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.305M	$1.097M	$1.097M
YoY Change	121.25%	287.24%	287.24%
TOTAL ASSETS
Total Short-Term Assets	$197.7K	$361.7K	$361.7K
Total Long-Term Assets	$1.305M	$1.097M	$1.097M
Total Assets	$1.503M	$1.459M	$1.459M
YoY Change	116.98%	327.59%	327.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$54.17K	$96.51K	$96.51K
YoY Change	119.58%	71.36%	71.36%
Accrued Expenses	$238.4K	$132.7K	$132.7K
YoY Change	208.78%	177.94%	177.94%
Deferred Revenue	$0.00	$0.00
YoY Change
Short-Term Debt	$185.0K	$185.0K	$185.0K
YoY Change	0.0%	0.0%	0.0%
Long-Term Debt Due	$1.619M	$576.8K	$576.8K
YoY Change	899.6%	12146.5%	12146.5%
Total Short-Term Liabilities	$2.096M	$991.0K	$991.0K
YoY Change	367.1%	237.34%	237.34%
LONG-TERM LIABILITIES
Long-Term Debt	$30.36K	$30.36K	$30.36K
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$30.36K	$30.36K	$30.36K
YoY Change	0.0%	-0.01%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.096M	$991.0K	$991.0K
Total Long-Term Liabilities	$30.36K	$30.36K	$30.36K
Total Liabilities	$2.127M	$1.021M	$1.021M
YoY Change	343.84%	215.11%	215.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.157M	-$8.260M
YoY Change	7.28%	14.19%
Common Stock	$125.5K	$122.6K
YoY Change	3.8%	2.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$50.00K	$50.00K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	-$623.9K	$437.2K	$437.2K
YoY Change
Total Liabilities & Shareholders Equity	$1.503M	$1.459M	$1.459M
YoY Change	116.98%	327.59%	327.58%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$218.0K	-$373.6K	-$1.027M
YoY Change	1.99%	-61.84%	4.85%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$126.6K	-$78.24K	-$340.8K
YoY Change	-19.69%	142.98%	-8.38%
INVESTING ACTIVITIES
Capital Expenditures	$116.0K	$250.4K	$805.4K
YoY Change	-15.97%	250.28%	184.34%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$116.0K	-$250.4K	-$805.4K
YoY Change	-15.97%	250.28%	184.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$149.3K
YoY Change			-140.11%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	256.9K	590.0K	1.449M
YoY Change	-14.45%	754.08%	139.56%
NET CHANGE
Cash From Operating Activities	-126.6K	-78.24K	-340.8K
Cash From Investing Activities	-116.0K	-250.4K	-805.4K
Cash From Financing Activities	256.9K	590.0K	1.449M
Net Change In Cash	14.36K	261.4K	303.1K
YoY Change	206.18%	-855.43%	-703.47%
FREE CASH FLOW
Cash From Operating Activities	-$126.6K	-$78.24K	-$340.8K
Capital Expenditures	$116.0K	$250.4K	$805.4K
Free Cash Flow	-$242.5K	-$328.6K	-$1.146M
YoY Change	-17.95%	216.96%	74.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	CLOQ	Website Website		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	CLOQ	Research Expenses ResearchExpenses		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	CLOQ	Loss On Settlement With Officer LossOnSettlementWithOfficer		usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023	CLOQ	Loss On Settlement With Officer And Director LossOnSettlementWithOfficerAndDirector		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware		usd
CY2023	CLOQ	Proceeds From Issuance Of Commonstock To Be Issued ProceedsFromIssuanceOfCommonstockToBeIssued		usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	us-gaap	Notes Issued1 NotesIssued1		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	124939754	shares
CY2023Q2	dei	Entity Public Float EntityPublicFloat	7095846	usd
CY2023	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC
CY2023	dei	Auditor Firm AuditorFirmId	5525
CY2023	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2023Q4	us-gaap	Cash Cash	307174	usd
CY2022Q4	us-gaap	Cash Cash	4067	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	44564	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	53811	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	361738	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	57878	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1090577	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	283240	usd
CY2023Q4	CLOQ	Website Website	6250	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1096827	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	283240	usd
CY2023Q4	us-gaap	Assets Assets	1458565	usd
CY2022Q4	us-gaap	Assets Assets	341118	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	96506	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56322	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	132685	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	47737	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	574718	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2623	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	2088	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	2088	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	990997	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	293770	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	30362	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	30362	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30362	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30362	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1021359	usd
CY2022Q4	us-gaap	Liabilities Liabilities	324132	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119089754	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119089754	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	122590	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	119090	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	20	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	20	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	50000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	50000	usd
CY2023Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2450000	shares
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2450000	shares
CY2023Q4	CLOQ	Shares To Be Issued SharesToBeIssued	149186	usd
CY2022Q4	CLOQ	Shares To Be Issued SharesToBeIssued	149186	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8475062	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7031812	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8259652	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7233122	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	437206	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16986	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1458565	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	341118	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15993	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2671	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	86778	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	424503	usd
CY2023	us-gaap	Officers Compensation OfficersCompensation	210000	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	207000	usd
CY2023	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	7818	usd
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	1011	usd
CY2023	CLOQ	Rent Expense RentExpense	9573	usd
CY2022	CLOQ	Rent Expense RentExpense	9117	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18927	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24796	usd
CY2023	CLOQ	Research Expenses ResearchExpenses	11036	usd
CY2023	us-gaap	Supplies Expense SuppliesExpense	9313	usd
CY2022	us-gaap	Supplies Expense SuppliesExpense	5848	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	29798	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	12733	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	383243	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	685088	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-367250	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-682337	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	94684	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	30786	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	564596	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	52623	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-195216	usd
CY2022	CLOQ	Loss On Settlement With Officer LossOnSettlementWithOfficer	18086	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-659280	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-296711	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1026530	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-979048	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	121035587	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	121035587	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	98649370	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98649370	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-35027	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-35027	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	474261	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	149810	usd
CY2022	CLOQ	Common Stock Issued For Settlement Of Debt CommonStockIssuedForSettlementOfDebt	335000	usd
CY2022	CLOQ	Stock Issued During Period Value Other One StockIssuedDuringPeriodValueOtherOne	12000	usd
CY2022	CLOQ	Adjustments To Additional Paid In Capital Stock Retirement Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalStockRetirementOfConvertibleDebt	50000	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	540000	usd
CY2022	CLOQ	Stock Issued During Period Value Preferred Stock Redeemed For Officers Settlement StockIssuedDuringPeriodValuePreferredStockRedeemedForOfficersSettlement	10	usd
CY2022	CLOQ	Reversal Of Common Stock Redeemed For Officers Settlement ReversalOfCommonStockRedeemedForOfficersSettlement	490000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	60000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-979048	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16986	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16986	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	149250	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1292500	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1026530	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	437206	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	437206	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1026530	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-979048	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	564596	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	52623	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	5000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	350643	usd
CY2022	CLOQ	Loss On Settlement With Officer And Director LossOnSettlementWithOfficerAndDirector	18086	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	195216	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10000	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-1023	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	32436	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	40184	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5335	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	84948	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	28288	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-340780	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-371963	usd
CY2023	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	800363	usd
CY2022	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	283240	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-805363	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-283240	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	149250	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	422075	usd
CY2022	CLOQ	Proceeds From Issuance Of Commonstock To Be Issued ProceedsFromIssuanceOfCommonstockToBeIssued	50000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2100	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	125000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1300000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	60000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000	usd
CY2023	CLOQ	Common Stock Issued For Prepaid Expense CommonStockIssuedForPrepaidExpense	4849	usd
CY2022	CLOQ	Common Stock Issued For Prepaid Expense CommonStockIssuedForPrepaidExpense	119260	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	141970	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	53000	usd
CY2020	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	321725	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zk8dS4UGZaTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zkATAMeHyRG1">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the year reported. Actual results may differ from these estimates. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	57174	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	84	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	8418	usd
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	10000000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	68000000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3000000	shares
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	719	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1096827	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	283240	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8259652	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1026530	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	10000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	10	usd
CY2022Q1	us-gaap	Severance Costs1 SeveranceCosts1	50000	usd
CY2022Q1	CLOQ	Gain Loss On Severance Costs GainLossOnSeveranceCosts	18076	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	500000	shares
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000	usd
CY2022Q1	us-gaap	Litigation Reserve LitigationReserve	490000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-195216	usd
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	500000	shares
CY2023	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	50000	usd
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	719	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2023Q4	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent	840000	usd
CY2022Q4	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent	60000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	150000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	150000	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2022Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	30000	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2022Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	30000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	42500	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	100000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	20000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	100000	usd
CY2023Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	45000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	60000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	15000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	15000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	10000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	10000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	300000	usd

Files In Submission

Name	View Source	Status
0001493152-24-011921-index-headers.html	Edgar Link	pending
0001493152-24-011921-index.html	Edgar Link	pending
0001493152-24-011921.txt	Edgar Link	pending
0001493152-24-011921-xbrl.zip	Edgar Link	pending
cloq-20231231.xsd	Edgar Link	pending
cloq-20231231_cal.xml	Edgar Link	unprocessable
cloq-20231231_def.xml	Edgar Link	unprocessable
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cloq-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
cloq-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

2024 Q2 Form 10-K Financial Statement

#000149315224011921 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLOQ CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

2024 Q2 Form 10-K Financial Statement

#000149315224011921 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq